Tuesday, October 27, 2026

EQT Q3 FY12/26 Earnings Review - Distribute Rating

EQT moved to Distribute at $56.29 after Q3 revenue fell 9.6%; a 44% trailing free-cash-flow margin signals cycle risk despite lower debt and an EPS beat.

EQT $34B

Cestrian Capital Research Oct 27 2 clicks

Oct 27 GFL $16B

My Last GFL Update - Hopefully

310 Value’s Newsletter 5 clicks

Oct 27 LITE $83B

Expert Call | Lumentum Optical Chip Capacity, EML/SiPh Outlook & Industry Pricing

P Equity Research 2 clicks

From X

@ACapitalLP Oct 27

A Capital on X

@310Value You don’t like the long $CWST / short $GFL pair trade? Nothing like shorting a live take-private situation to hedge an activist margin improvement story.

@ACapitalLP Oct 27

A Capital on X

@richtrades100 Isn’t it worse now that $MGM stock is lower and $PPLI is higher? Have to issue more stock as currency…

@StableBread Oct 27 2 clicks

Fajasy on X

@babyfolio @StonkChris Havent dug in much but from what i seen and heard market seems to be real wrong om $CBRS

@ACapitalLP Oct 27 1 click

A Capital on X

@KEDM_COM These guys are also in $ZD - Czech based activist fund?

@BarbarianCap Oct 27 2 clicks

Barbarian Capital on X

Robinhood quarterly revenue rises 12% as event contracts, options offset crypto slump $HOOD https://t.co/OuqJoAA9Fy

@ParadisLabs Oct 27 1 click

Paradis on X

A lot of green in AI land today from $NBIS +11.2% to $CRDO +10.8%. Over the past few weeks, financing has been the main pressure point but it seems like we've made some solid progress this week. - $META raised $97.5B, with $60B of that coming through an ATM starting in January. - $SPCX signed a $40B deal for GPU equipment. - $AVGO set up a $63B SPV to fund custom chips for Anthropic, who also eased some fears with their S-1. Feels like the rapid de-grossing over the last few weeks has mostly run its course, however according to JPM, volumes still remain light. Interestingly, GS say that there's evidence today of "increased offense being played across the AI complex". While this is still minimal, it's a notable uptick vs. the past few weeks where risk was near zero. I wonder whether the market decides to pay attention to the upcoming hurdles, or whether it keeps riding the wall of worry higher. I personally still land on some short-term choppiness when you consider how bruised investors have gotten since July + hurdles in the next few days (hyperscaler earnings, FOMC, midterms).

@Mr_Neutral_Man Oct 27

Mr Neutral Man aka "Howard Marks of REITs” on X

Only one stock is down double digits in both the 1st and 2nd half $CHTR https://t.co/knuRdXweGS

@eriksen_tim Oct 27

Tim Eriksen on X

@ericgold34 Been buying $UBAB lately. A few I have not followed closely. Some are very illiquid.

Novartis (NYSE: NVS) Stock Rating: Do Nothing After Q3 FY12/26 Earnings

Novartis grew Q3 sales 4% to $14.5bn and raised profit guidance, but pipeline failures triggered a $1.9bn impairment as net debt reached…

NVS $296B

Cestrian Capital Research Oct 27 3 clicks

AppFolio 3Q26 Business Recap: AI Agents Support Growth

AppFolio grew third-quarter revenue 19% as Realm-X AI agents gained adoption, lifting guidance to $1.122 billion to $1.127 billion.

APPF $7.6B

Speedwell Research Oct 27 5 clicks

Boeing (NYSE: BA) Stock Rating: Do Nothing After Q3 FY12/26 Earnings

Boeing posted $24.2 billion in Q3 revenue and $1.5 billion in operating cash flow, but commercial aircraft lost $697 million as production…

BA $136B

Cestrian Capital Research Oct 27 1 click

TTM Technologies: The Market Already Caught On To Peak Numbers

TTM Technologies’ record Q3 and data-center exposure drove a 27.7% stock drop as investors questioned debt-funded growth, leverage and the…

TTMI $8.6B

Nicolas Bolsinger Oct 27 1 click

Are Neoclouds Dead?

Neoclouds face tighter debt financing as AI infrastructure capex outruns cash flow, leaving cash-burning GPU providers more exposed than…

NBIS $46B

Daniel Romero Oct 27 9 clicks

Quantinuum: A Quantum Leader At A Reasonable Value

Quantinuum’s trapped-ion quantum platform supports a $2 billion 2030 revenue estimate and $135 fair value, backed by $2.1 billion cash and…

QNT $1.6B

Fundamental Options Oct 27 5 clicks

Reddit: Deep Dive Analysis

Reddit generated $805 million in Q2 2026 revenue, 95% from ads, but slowing Google search referrals expose AI-driven traffic and…

RDDT $26B

Hated Moats Oct 27 6 clicks

Qualcomm Inc. (QCOM)

Qualcomm supplies chips for on-device AI agents and data center inference, with Meta and AWS agreements expanding its role across both…

QCOM $195B

SixSigmaCapital: Navigating the Financial Markets Oct 27 5 clicks

Single Stock Spotlight #17: Gamestop (GME)

GameStop’s $6.1 billion in net cash equivalents and shift toward collectibles underpin a $30 to $40 per-share valuation thesis.

GME $12B

Hidden Rock Capital's Newsletter Oct 27 4 clicks

Monte Investments Market Brief Vol. CXXXIII

Monte Investments updates Carpenter Technology after a 25% sell-off, tracks EQT’s $12.83 billion Range Resources acquisition and assesses…

CRS $15BKRMN $5B

Monte Independent Investment Research Oct 27 1 click

ATS · long

Ats CORP

ATS Corporation is a turnaround under new leadership, targeting secular growth opportunities.

ATS $1.9B

Value Investors Club Jul 29

Spotify 3Q’26: Built for the Background

Spotify's third-quarter results met or exceeded guidance, with 306 million Premium subscribers and €672 million operating income, while…

SPOT $114B

MBI Deep Dives Oct 23 4 clicks

TSOH Weekly Roundup (10/23/2026)

TSOH Weekly Roundup covers Ally’s improving credit and capital returns, Pepsi’s weak beverage brands, and Match Group’s plan to revive…

ALLY $12BMTCH $10B

TSOH Investment Research Oct 23 5 clicks

Texas Instruments (NASDAQ: TXN) Stock Rating: HOLD After Q3 FY12/26 Earnings

Texas Instruments reported Q3 revenue of $6.06 billion, up 28%, with 47% operating margin and Q4 guidance above seasonal norms; Cestrian…

TXN $283B

Cestrian Capital Research Oct 23 7 clicks

Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch

Tempus AI targets $1.6 billion of 2026 revenue through AI diagnostics, data licensing and cancer-testing partnerships, with Personalis…

TEM $13BMRNA $83B

Edmund Ingham Oct 23 7 clicks

Research & Analysis: ERock, Inc. (NYSE: EROC)

ERock’s modular microgrids bridge data-center power gaps years before grid interconnects, with Meta and Anthropic projects filling capacity…

EROC $444M

Monte Independent Investment Research Oct 23 10 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $19B

Best Anchor Stocks Oct 23 15 clicks

Lockheed Martin Q3 FY12/26 Earnings Review

Lockheed Martin's Q3 missile sales rose 24% on PAC-3, THAAD, GMLRS and PrSM ramps, lifting Missiles and Fire Control backlog to $142.5…

LMT $145B

Cestrian Capital Research Oct 23 6 clicks

Industry Primers Podcast: Natural Resources Royalty & Streaming, Part One: The Story

Franco-Nevada, Wheaton and Texas Pacific Land built royalty and streaming businesses by buying fixed shares of mines and wells, tracing the…

FNV $46BWPM $52B

Latticework by MOI Global Oct 23 5 clicks

Oscar Health: Up Over 200% From The March Lows, Still Room To Run (Ticker: OSCR)

Oscar Health raised 2026 operating earnings guidance to $600 million-$800 million after ACA-marketplace expansion drove 60% membership and…

OSCR $9.7B

Emerging Moats Research Oct 23 5 clicks

Tuesday, October 27, 2026

A Capital on X

A Capital on X

Fajasy on X

A Capital on X

Barbarian Capital on X

Paradis on X

Mr Neutral Man aka "Howard Marks of REITs” on X

Tim Eriksen on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 266

X accounts we follow

Investor letters we follow

Sectors